Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OK great post about AMBS.. if your track record maintains..
Rocket to the Top for AMBS
Keep up great work.. Longs Appreciate it.
Thanks for your efforts to raise the PPS of BMSN... do it again tomorrow. your posts push this in the right direction. UP!!!
Appreciate all your effort, really do. its working
I want to give Thanks to all the DD done by an organized group of long AMBS Investors here, it is greatly appreciated by most..
some few continue their different methods of questioning their hard work without providing anything to the board other than some smart remarks of AMBS Going to .01 or Quoting and nit picking every post that has actual DD.. to each his own. we can only assume their intentions.
I just wanted to say thank you.. to all the GOOD DD here from posters who provide it.
AMBS $$$
you asked for source of funding referring to that other post .. i showed you the links..
not much to misinterpret MJFOX is not going to stop helping MANF research when he was just shown how much more effective it was at this stage than GDNF.
I can connect the Dots you seem not able to.. but you want to see the actual photo of MJFOX handing them the new Check to put it together.. sorry... you will have to wait for that inevitable Photo. not too long though.
but have a nice night
thanks again... that means I'm right
GL2U keep up awesome job.
not many people can talk negative about something and make it a positive ++++
here is the source straight from MJ FOX
https://www.michaeljfox.org/foundation/grant-detail.php?grant_id=644
enjoy the read about MANF & AMBS
Says it right in the source " The lead MANF product development effort is centered on a therapy for Parkinson's disease, currently funded by a research grant from the Michael J. Fox Foundation for Parkinson’s Research".
maybe you are not good at connecting the dots, not everyone can.
http://www.bizjournals.com/sanjose/stories/2010/04/26/daily50.html
Nice keep it up. You were all over it today. Well done nice calls
Not u short covered at a loss.
Leave him be. He brings good luck to longs. He worked wonders on BMS* today. Every prediction went opposite. I like him let him post away
U should Cover imo
You know whos better cover.
GDNF =$270 Million MANF is Better Molecule
$550 Million? $750 Million?
I say this is just for 1 indication ...
IMO
<<AMBS>> WoW MUST READ!!!!!!!!!!!!!
Longs have locked the AMBS float. Charts moving side ways now. On radar!
This week we are
ON THE WAY UP>>>>>>> AMBS $$$$
BMSN = BARCHART STRONG BUY STILL !!!!
and remember don't let anyone one deter you from success
switching to a cash account helps.. but the GTC does not work..
NO Dilution.. Do Some DD and see
I do not see any SEC Filings for the so-called dilution.. so you are mistaken completely.. AMBS is a company that does things legitimately not like other companies you may have invested in before.
check this link for all the DD you need:
https://docs.google.com/document/d/1ruRFkL3XpVpD1pbCRV0Fj-X5gJ8s3MAyhviP2UVgTMw/edit
thats right thanks for the tip...
but like this he will more cash when he is forced to buy AMBS at a higher price
Most drug begin being tested on mice, most then to primates, then to Human trials.
difference here is MANF is derived from a natural protein in the Human body.
With Orphan Drug status.. MANF will be streamlined straight from Mice to MAN....IMO
this is the excitement of Dr. Joeseph Rubinfeld... he told you about this himself..
AMBS has closed a $10M Equity Funding Facility from before,, they can still draw from this if they want to... since they have hardly needed it most of it is unused. 36 Months means they have access to it until OCT. 2014
AMBS will have plenty cash soon, its inevitable
SUNNYVALE, CA--(Marketwire - Oct 13, 2011) - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death known as apoptosis, announced today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC ("Centurion"). The Company will have the ability to draw down on this facility over the course of the next 36 months in tranches of up $750,000, subject to certain conditions and limitations described in the agreement, including limitations based upon the price and trading volume of the Company's common stock, upon the successful registration of the common shares underlying the facility with the Securities & Exchange Commission.
http://www.marketwire.com/press-release/amarantus-biosciences-announces-close-10m-equity-funding-facility-with-centurion-private-otcbb-ambs-1572738.htm
AMBS has closed a $10M Equity Funding Facility from before,, they can still draw from this if they want to... since they have hardly needed it most of it is unused. 36 Months means they have access to it until OCT. 2014
AMBS will have plenty cash soon, its inevitable
SUNNYVALE, CA--(Marketwire - Oct 13, 2011) - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death known as apoptosis, announced today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC ("Centurion"). The Company will have the ability to draw down on this facility over the course of the next 36 months in tranches of up $750,000, subject to certain conditions and limitations described in the agreement, including limitations based upon the price and trading volume of the Company's common stock, upon the successful registration of the common shares underlying the facility with the Securities & Exchange Commission.
http://www.marketwire.com/press-release/amarantus-biosciences-announces-close-10m-equity-funding-facility-with-centurion-private-otcbb-ambs-1572738.htm
That is correct, Thanks Mike AMBS & ARRAYIT JV should be announced soon also..
AMBS is covering all angles... they have a plan and its coming to fruition
AMBS$$$$$$$$$$
not concerning at all.. the new tests are re-validating Ground Breaking Findings..It is normal protocol
the problem here is it seems you are impatient , be patient and you will be rewarded by investing in AMBS. i hope you don't let yourself get in your own way of making money here.
AMBS has a very bright future, such a bright future that 5 years from now you will be either hitting your head against the wall screaming why did i sell so early or on a beach chair on a tropical island enjoying frozen drinks.. saying AMBS is Awesome
Nice Find, but it wont save money it is actually an add on test that will lead the patients to the NUROPRO Blood test for biomarkers. as it is stated in the column
Here is a link to some great DD for AMBS
https://docs.google.com/document/d/1V10erwVdBvy6Um35Ay8XV0wV3TAPr6oME2fJG_jFvl4/edit
KNOW WHAT YOU OWN
AMBS
The lead MANF product development effort is centered on a therapy for Parkinson's disease, currently funded by a research grant from the Michael J. Fox Foundation for Parkinson’s Research. The Company also owns an inventory of 88 cell lines referred to as “PhenoGuard Cell Lines.” MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. It is anticipated that additional therapeutic proteins useful for various therapeutic approaches to the Central Nervous System will be identified from the Company’s inventory of PhenoGuard Cell Lines.
Source: http://ih.advfn.com/p.php?pid=nmona&article=49757501
We have high confidence MJFF will renew their grant since The most recent test results came back very positive, so AMBS has advanced greatly since MJFF issued previous grant.
the Biomarker for PD is the evidence..
interpret it however you want..
AMBS having patents on 47 Protein Biomarkers for Neurodegenerative Diseases including PD. you can see the connection right?
With the acquisition of these assets, Amarantus added following issued patents to its portfolio:
12/802,630 – Diagnosis of Parkinson’s Disease
13/118,175 – Assays for diagnosis and therapeutics…ALS and Parkinson’s Disease
12/069,807 – 47 Protein Biomarkers for Neurodegenerative Diseases
12/804,868 – Assays for Amyotrophic Lateral Sclerosis (ALS) and ALS-like disorders
13/153,669 – Diagnosis of Alzheimer’s Disease
http://www.redorbit.com/news/health/1112754065/amarantus-bioscience-acquires-neurodegenerative-diagnostic-intellectual-property-portfolio-from-power3/
VERY NICE CHART SET UP FOR AMBS
thanks for that nice work
HEAVY SHORTING OF BMSN... MOASS COMING
http://otcshortreport.com/BMSN
Check here how many shares per day.... PERFECT STORM BREWING
Mother of all short sqeeeeeeeezes
AMBS = Legitimate future Block Buster Drug producer
and that Google doc had the all the Factual DD.. and it is removed by someone other than the original poster. makes you wonder doesn't it?
AMBS POST OF THE YEAR ...
FACTS!!! TRUTH !!!!!
INEVITABLE UPSIDE
$$$$ AMBS $$$$
AMBS SHORTS ARE RISKING UNLIMITED LOSSES
Once the FUNDING/BUYOUT PR is released you will see the frenzy
this is inevitable, most are impatient and want a quick buck.
but the ones who are patient will be rewarded the most.
they try to keep it down but they know they can't , so they resort to non-factual statements.
DO your own DD... I have.
The group of Management, Advisors, Scientists ,Foundations, PhD's associated with AMARANTUS say AMBS is a WORLD CLASS Company and its success is the inevitable FACT here..
HEAVY SHORTING OF BMSN... MOASS COMING
http://otcshortreport.com/BMSN
Check here how many shares per day.... PERFECT STORM BREWING
Mother of all short sqeeeeeeeezes
BMSN she probably lost money on ENT* a while back because of poor trading experience bought high sold low out of panic.... now she bashes stock. axe to grind with KOOS
MOTHER OF ALL SHORT SQUEEZES = BMSN
M.O.A.S.S.
explains a lot of its detractors intentions....
nice try.... i just called Charles Schwab and they don't know any Paris Hilton and they own part of BARCHART
BARCHART SAYS = STRONG BUY
BMSN
That's cool, In regards to BMSN I Have a friend at Morgan Stanley 30 years experience who disagrees with your less experienced acquaintance
BARCHART SAYS = STRONG BUY $$$$